Affirm Holdings, Inc. is a San Francisco-based financial technology company that operates a buy-now-pay-later (BNPL) platform enabling consumers to split purchases into fixed, transparent installment loans with no hidden fees. Founded in 2012, the company partners with over 515,000 active merchants across categories including retail, travel, outdoor recreation, and home goods. Affirm generates revenue through merchant fees and interest income on consumer loans, underwriting each transaction individually using proprietary risk-assessment technology. Its product ecosystem includes a consumer-facing app, the Affirm Card, virtual card capabilities, and integrated checkout solutions. The company competes with traditional credit card issuers and fintech peers such as SoFi Technologies (SOFI) and PayPal (PYPL), while differentiating itself through a no-late-fee model and real-time credit decisioning. Investors follow AFRM closely given its rapid merchant network expansion, gross merchandise volume growth, and the ongoing evolution of the BNPL industry from transaction financing toward everyday money management. When I scanned comparable names in the space, I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, Affirm shares moved from a closing price of $70.73 on June 17, 2026, to $79.84 at market close on July 16, 2026, representing a gain of approximately 12.9%. The stock experienced notable momentum in late June, rallying from $62.81 on June 10 to an intra-period peak of $86.55 on July 2 before consolidating in the $80–$85 range through mid-July. Over the broader quarter starting from April 17, when shares closed at $64.50, the stock has surged roughly 23.8%, reflecting sustained upward momentum. The quarterly trend was marked by a powerful April rally of over 40%, followed by a choppy May and a renewed advance in late June through early July. The 50-day simple moving average has climbed to approximately $72, signaling strong near-term momentum, while the 200-day moving average sits near $63.50, underscoring longer-term appreciation from the $45 range seen in early April.
The 12.9% gain over the last 30 days was fueled by a confluence of positive analyst actions, strategic partnerships, and improving financial metrics. On June 25, Susquehanna raised its price target to $105, citing growth potential based on Adobe Analytics data and management discussions. Piper Sandler followed on June 29, reiterating an Overweight rating and setting a $103 target, arguing that BNPL is entering a second phase centered on everyday money management — a shift that favors Affirm's expanding product suite, including the Affirm Card and Edge offering. On July 1, Citigroup raised its target from $100 to $115, maintaining a Buy rating. On July 10, Barclays upgraded the stock to "strong-buy," reinforcing the bullish sentiment. On the partnership front, Affirm announced a significant $1.7 billion forward-flow agreement with CPP Investments, expandable to $2.2 billion, which is expected to support approximately $8 billion in consumer loan volume over two years. The company also added Bed Bath & Beyond and Backcountry to its merchant network, broadening its reach in home goods and outdoor recreation. The appointment of former Capital One executive Ryan Schneider to the board further signaled a focus on credit and underwriting expertise. On the earnings front, the company's Q3 fiscal 2026 results delivered EPS of $0.30, well above the $0.17 consensus, though revenue of $943.95 million came in below analyst estimates of roughly $995 million. Citizens maintained a Market Outperform rating and $85 target on July 16, noting stable credit data and resilient consumer spending despite energy price concerns.
Affirm's 23.8% quarterly gain was underpinned by a powerful April rebound, during which the stock rallied over 40% as Morgan Stanley named AFRM a "Top Pick," citing upward estimate revision potential and calling private credit fears "overdone." The company's expanded partnership with Stripe to support agentic commerce through Shared Payment Tokens added to the technological narrative. The May 7 Q3 earnings release, which showed a 32.7% year-over-year revenue increase and a swing to GAAP profitability, validated the bullish thesis. The company's Investor Day in mid-May provided updated medium-term guidance, with management indicating revenue growth expectations above 20% and refining margin targets — a presentation Citi had flagged ahead of time with a "90-Day Catalyst Watch" designation. Throughout the quarter, multiple analyst firms raised price targets, including Cantor Fitzgerald (from $61 to $80), Deutsche Bank (to $85), and Truist (to $80). The merchant count grew 44% year-over-year to 515,000, and gross merchandise volume rose 35% to $11.6 billion in Q3 alone, with full-year GMV guidance of $49.265–$49.565 billion. These metrics reinforced the narrative that Affirm's network effect is strengthening across diverse retail verticals.
In my own research process, I sometimes look at automated approaches to complement fundamental analysis, especially when monitoring momentum in fintech names. For traders seeking automated strategies tailored to stocks like Affirm, Tickeron's Trending AI Robots page offers a curated selection of top-performing AI trading bots. Tickeron hosts hundreds of AI-driven bots that trade thousands of tickers across diverse strategies, timeframes, and performance metrics, but only the most relevant and consistently strong performers are highlighted in this section. Each bot uses pattern recognition and algorithmic analysis to identify potential trading opportunities without human emotional bias. Bots vary in approach — some focus on short-term swing trades, while others target longer-duration trends — allowing users to find strategies aligned with their own risk tolerance and investment style. Exploring the Trending AI Robots page can help investors discover automated tools designed to navigate evolving market conditions.
Looking ahead, several factors will influence Affirm's trajectory. The company's next quarterly earnings report will be closely scrutinized for sustained profitability, GMV growth, and credit performance metrics amid ongoing debate about consumer health and delinquency rates. Macroeconomic conditions — particularly interest rate policy, energy prices, and employment data — will play a decisive role in shaping consumer borrowing behavior and Affirm's funding costs. The company's ability to maintain and expand its merchant network, especially with large enterprise partners, remains central to its growth narrative. Regulatory developments around BNPL products, including potential consumer protection rules and fee disclosure requirements, could introduce new compliance costs. Investor attention will also focus on the performance of newer initiatives such as the Affirm Card and AdaptAI-driven margin optimization. Competitive pressure from traditional banks and fintech rivals entering the installment-payment space may test Affirm's pricing power and market share. While analyst consensus remains tilted toward Buy with an average price target near $90, the wide dispersion of targets — from $79 to $115 — reflects genuine uncertainty about the pace at which Affirm can convert merchant expansion into sustained, capital-efficient profitability.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AFRM saw its Momentum Indicator move below the 0 level on July 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned negative. In of the 79 cases, the stock moved further down in the following days. The odds of a decline are at .
The 10-day RSI Indicator for AFRM moved out of overbought territory on July 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for AFRM turned negative on July 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AFRM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 50-day moving average for AFRM moved above the 200-day moving average on June 24, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AFRM advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .
AFRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 261 cases where AFRM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AFRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AFRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.734) is normal, around the industry mean (4.473). AFRM's P/E Ratio (69.155) is considerably higher than the industry average of (19.826). Projected Growth (PEG Ratio) (0.763) is also within normal values, averaging (1.194). Dividend Yield (0.000) settles around the average of (0.067) among similar stocks. P/S Ratio (6.920) is also within normal values, averaging (6.405).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry SavingsBanks